ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 25

$521K Total Retail Price of All Prescriptions

Rank: 9 out of 25

329 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 11,792 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 646 598 1 3
OMEPRAZOLE 483 423 2 4
FUROSEMIDE 430 376 3 7
POTASSIUM CHLORIDE 317 295 4 12
AMLODIPINE BESYLATE 305 292 5 2
GABAPENTIN 296 292 6 10
METOPROLOL TARTRATE 289 274 7 17
LEVOTHYROXINE SODIUM 288 240 8 6
HYDROCODONE-ACETAMINOPHEN 260 216 S3 9 1
DIGOXIN 249 218 10 47
ENALAPRIL MALEATE 227 219 11 38
WARFARIN SODIUM 220 175 12 15
ATENOLOL 195 183 13 31
LOSARTAN POTASSIUM 187 161 14 36
TAMSULOSIN HCL 182 182 15 33
HYDROCHLOROTHIAZIDE 178 174 16 9
METOPROLOL SUCCINATE 166 166 17 14
METFORMIN HCL 165 151 18 8
ISOSORBIDE MONONITRATE ER 161 149 19 40
GLIMEPIRIDE 147 141 20 35
CRESTOR 146 129 21 44
CARVEDILOL 140 113 22 19
ATORVASTATIN CALCIUM 131 130 23 22
ALENDRONATE SODIUM 127 127 24 59
CLOPIDOGREL 124 113 25 28
EVISTA 120 120 26 130
HYDRALAZINE HCL 119 95 27 67
ALLOPURINOL 113 80 28 29
LISINOPRIL 111 97 29 5
PLAVIX 104 90 30 37
SPIRONOLACTONE 101 82 31 53
DOXYCYCLINE HYCLATE 97 79 32 78
RAMIPRIL 96 96 33 101
SYNTHROID 92 92 34 79
PRAVASTATIN SODIUM 90 90 35 11
CILOSTAZOL 83 80 36 185
CITALOPRAM HBR 83 78 36 18
RANITIDINE HCL 82 79 38 26
NEXIUM 81 64 39 24
DONEPEZIL HCL 80 80 40 13
METHYLPREDNISOLONE 79 76 41 191
LOVASTATIN 73 69 42 30
COUMADIN 73 73 42 203
SERTRALINE HCL 72 60 44 25
AMIODARONE HCL 72 60 44 121
BENAZEPRIL HCL 72 69 44 76
DOXEPIN HCL 72 72 44 132
TRAMADOL HCL 71 71 48 23
LOSARTAN-HYDROCHLOROTHIAZIDE 71 71 48 63
LACTULOSE 69 55 50 100
NIFEDIPINE ER 69 57 50 119
QUETIAPINE FUMARATE 67 67 52 42
POLYETHYLENE GLYCOL 3350 66 56 53 66
NAMENDA 66 66 53 16
ZOLPIDEM TARTRATE 65 65 55 21
CLONIDINE HCL 64 62 56 32
IBUPROFEN 60 60 57 103
AMLODIPINE BESYLATE-BENAZEPRIL 60 60 57 61
MELOXICAM 58 48 59 20
GLYBURIDE 56 32 R 60 105
PREDNISONE 56 56 60 46
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 52 62 128
CHLORTHALIDONE 52 37 62 164
ESCITALOPRAM OXALATE 51 45 64 81
KLOR-CON M10 50 38 65 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.